Your browser doesn't support javascript.
loading
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation.
Salas, Maria Queralt; Atenafu, Eshetu G; Pasic, Ivan; Bascom, Ora; Wilson, Leeann; Lam, Wilson; Law, Arjun Datt; Chen, Carol; Novitzky-Basso, Igor; Kim, Dennis Dong Hwan; Gerbitz, Armin; Viswabandya, Auro; Michelis, Fotios V; Lipton, Jeffrey Howard; Mattsson, Jonas; Alibhai, Shabbir M H; Kumar, Rajat.
Afiliação
  • Salas MQ; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Atenafu EG; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Pasic I; HCT Unit, Hospital Clinic de Barcelona, ICHMO, Barcelona, Spain.
  • Bascom O; Department of Biostatistics, Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Wilson L; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Lam W; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Law AD; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Chen C; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Novitzky-Basso I; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Gerbitz A; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Michelis FV; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Mattsson J; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Alibhai SMH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Kumar R; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
Bone Marrow Transplant ; 58(11): 1237-1246, 2023 11.
Article em En | MEDLINE | ID: mdl-37620424
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Fragilidade Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Fragilidade Idioma: En Ano de publicação: 2023 Tipo de documento: Article